Download PDF

Marco Dolci leads the Cardiopulmonary business unit for LivaNova. He joined LivaNova in 2017, coming from Danaher Corporation where he served as Vice President Danaher Business System-Dental Consumable Platform, earlier he was President Global Digital Dentistry and President Kerr EMEA and ASIA. Prior to his tenure at Danaher, Dolci served as President and CEO, EMEA for Hitachi Medical System Europe Holding AG. Earlier in his career, he worked in various positions at Eastman Kodak S.A. – Health Care Division, GE Healthcare and Philips Medical Systems. Dolci has more than 30 years of experience working in the healthcare and medical device industries.


Dolci earned a master’s degree in nuclear physics from University of Milan and an Executive MBA from Polytechnic University of Milan.

«« Blood Clot Testing Using Smartphones


Call for Submissions - HealthManagement.org The Journal  »»


president, Marco Dolci, Cardiopulmonary Global BU , LivaNova

Latest Articles

  • Pharmacist in the ICU

    Pharmacists play a crucial role in the ICU, where patients often require complex medication regimens, including multiple medications and intravenous therapies. The role of a critical care pharmacist is multifaceted and vital to ensuring optimal patient care in the critical care setting.   Cr

    READ MORE
  • Defining Medicines Optimisation in the Intensive Care Unit

      Complex polypharmacy and pathophysiology are common in the intensive care unit (ICU). Medicines optimisation is essential to deliver safe, effective, and individualised pharmacotherapy. This is ideally performed by a specialised ICU pharmacist.   Introduction Medicines ar

    READ MORE
  • Critical Care Pharmacists Save Lives

      The purpose of this review is to discuss the role of critical care pharmacists on the interprofessional healthcare team in the care of critically ill patients and explore current gaps in the provision of comprehensive medication management.   Introduction   “The patient’s

    READ MORE
Marco Dolci,President,Cardiopulmonary Global BU ,LivaNova Marco Dolci leads the Cardiopulmonary business unit for LivaNova. He joined LivaNova in 2017, coming from Danaher Corporation where he served as Vice Pres...